-
LIVER CANCER 2024 10.1159/000539724
Prognostic Efficacy of the Albumin-Bilirubin Score and Treatment Outcomes in Hepatocellular Carcinoma: A Large-Scale, Multi-Center Real-World Database Study
Kim, KP; Kim, KM; Ryoo, BY; Choi, WM; Cha, WC; Kang, MR; Sinn, DH; Goh, MJ; Kim, D; Lee, MJ; Lim, S; Kim, D; Baek, K; Kim, J; Choi, EJ; Lee, DK; Kim, JA; Kim, KH
View PubMed
-
ALIMENT PHARM THER 2024 10.1111/apt.18402
Serum Ferritin Levels and Liver-Related Events in Individuals With Steatotic Liver Disease: A Longitudinal Cohort Study
Song, BG; Goh, MJ; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Sinn, DH
View PubMed
-
J KOREAN MED SCI 2024 10.3346/jkms.2024.39.e251
Modified Albumin-Bilirubin Grade After Curative Treatment: Predicting the Risk of Late Intrahepatic Recurrence of Hepatocellular Carcinoma
Goh, MJ; Park, HC; Kim, N; Bae, BK; Choi, MS; Rhu, J; Lee, MW; Jeong, WK; Kim, M; Kim, K; Yu, JI
View PubMed
-
PLOS ONE 2024 10.1371/journal.pone.0307712
Similar recurrence after curative treatment of HBV-related HCC, regardless of HBV replication activity
Kim, MN; Kim, BK; Cho, H; Goh, MJ; Roh, YH; Yu, SJ; Sinn, DH; Park, SY; Kim, SU
View PubMed
-
CANCERS 2024 10.3390/cancers16152652
Glycemic Burden and Clinical Outcomes of Early Stage Hepatocellular Carcinoma after Curative Treatment
Lee, HJ; Choi, MS; Song, BG; Kang, WS; Gwak, GY; Goh, MJ; Paik, YH; Lee, JH; Sinn, DH
View PubMed
-
GUT LIVER 2024 10.5009/gnl240085
Analysis of Factors Predicting the Real-World Efficacy of Atezolizumab and Bevacizumab in Patients with Advanced Hepatocellular Carcinoma
Song, BG; Goh, MJ; Kang, WS; Sinn, DH; Gwak, GY; Choi, MS; Lee, JH; Paik, YH
View PubMed
-
SCI REP-UK 2024 10.1038/s41598-024-66253-0
Hepatocellular carcinoma outcomes and potential implications for surveillance in elderly patients
Kim, A; Park, G; Goh, MJ; Song, BG; Kang, WS; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Sinn, DH
View PubMed
-
KOREAN J INTERN MED 2024 10.3904/kjim.2023.354
Prevalence and predictors of multidrug-resistant bacteremia in liver cirrhosis
Kim, A; Song, BG; Kang, WS; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Goh, MJ
View PubMed
-
J CLIN MED 2024 10.3390/jcm13092588
Massive Transfusion Protocol and Outcome of Patients with Acute Variceal Bleeding
Kim, A; Sinn, DH; Song, BG; Goh, MJ; Hwang, SY; Ko, RE; Chung, CR; Park, CM
View PubMed
-
LIVER CANCER 2024 10.1159/000538301
Risk of Hepatocellular Carcinoma by Steatotic Liver Disease and Its Newly Proposed Subclassification
Song, BG; Kim, A; Goh, MJ; Kang, WS; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Sinn, DH
View PubMed
-
NPJ DIGIT MED 2024 10.1038/s41746-023-00976-8
Machine learning-based clinical decision support system for treatment recommendation and overall survival prediction of hepatocellular carcinoma: a multi-center study
Lee, KH; Choi, GH; Yun, J; Choi, J; Goh, MJ; Sinn, DH; Jin, YJ; Kim, MA; Yu, SJ; Jang, S; Lee, SK; Jang, JW; Lee, JS; Kim, D; Cho, YY; Kim, HJ; Kim, S; Kim, JH; Kim, N; Kim, KM
View PubMed
-
RADIOTHER ONCOL 2023 10.1016/j.radonc.2023.109841
External validation of subclassification system and progression pattern analysis in hepatocelluar carcinoma with macroscopic vascular invasion
Yu, JI; Park, HC; Shin, H; Park, H; Shin, SW; Cho, SK; Hyun, D; Shin, J; Goh, MJ; Choi, MS; Park, B; Yoon, SM; Jung, JH
View PubMed
-
JHEP REP 2023 10.1016/j.jhepr.2023.100810
Metabolic dysfunction-associated fatty liver disease and the risk of hepatocellular carcinoma
Song, BG; Choi, SC; Goh, MJ; Kang, WS; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Paik, SW
View PubMed
-
LIVER INT 2023 10.1111/liv.15632
Validation of non-invasive diagnosis of CSPH in patients with compensated advanced chronic liver disease according to Baveno VII
Song, BG; Goh, MJ; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Paik, SW; Sinn, DH
View PubMed
-
SCI REP-UK 2023 10.1038/s41598-023-36668-2
Improved on-treatment fibrosis-4 during antiviral therapy and lower hepatocellular carcinoma risk in cirrhotic patients with hepatitis B
Oh, JH; Park, Y; Goh, MJ; Sinn, DH; Ahn, SB; Kang, WS; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Paik, SW
View PubMed
-
CLIN MOL HEPATOL 2023 10.3350/cmh.2022.0404
Clinical practice guideline and real-life practice in hepatocellular carcinoma: A Korean perspective
Goh, MJ; Sinn, DH; Kim, JM; Lee, MW; Hyun, DH; Il Yu, J; Hong, JY; Choi, MS
View PubMed
-
GUT LIVER 2023 10.5009/gnl220420
Clinical Outcomes and Validation of Ursodeoxycholic Acid Response Scores in Patients with Korean Primary Biliary Cholangitis: A Multicenter Cohort Study
Chang, JI; Kim, JH; Sinn, DH; Cho, JY; Kim, KM; Oh, JH; Park, Y; Sohn, W; Goh, MJ; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
View PubMed
-
GUT LIVER 2023 10.5009/gnl220337
Pretransplant Functional Status Predicts Postoperative Morbidity and Mortality after Liver Transplantation in Patients with Cirrhosis
Goh, MJ; Kim, J; Chang, WH; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW; Kim, JM; Kang, WS
View PubMed
-
EUR J GASTROEN HEPAT 2023 10.1097/MEG.0000000000002466
Sorafenib versus nivolumab after lenvatinib treatment failure in patients with advanced hepatocellular carcinoma
Kim, Y; Lee, JS; Lee, HW; Kim, BK; Park, JY; Kim, D; Ahn, SH; Goh, MJ; Kang, W; Kim, SU
View PubMed
-
LIVER CANCER 2023 10.1159/000529635
Impact of Intrahepatic External Beam Radiotherapy in Advanced Hepatocellular Carcinoma Patients Treated with Tyrosine Kinase Inhibitors
Goh, MJ; Park, HC; Yu, JI; Kang, WS; Gwak, GY; Paik, YH; Lee, JH; Koh, KC; Paik, SW; Sinn, DH; Choi, MS
View PubMed
-
LIVER CANCER 2022 10.1159/000525145
Real Life Study of Lenvatinib Therapy for Hepatocellular Carcinoma: RELEVANT Study
Casadei-Gardini, A; Rimini, M; Kudo, M; Shimose, S; Tada, T; Suda, G; Goh, MJ; Jefremow, A; Scartozzi, M; Cabibbo, G; Campani, C; Tamburini, E; Tovoli, F; Ueshima, K; Aoki, T; Iwamoto, H; Torimura, T; Kumada, T; Hiraoka, A; Atsukawa, M; Itobayashi, E; Toyoda, H; Sakamoto, N; Sho, T; Kang, W; Siebler, J; Neurath, MF; Burgio, V; Cascinu, S
View PubMed
-
CLIN MOL HEPATOL 2022 10.3350/cmh.2021.0366
Statin and aspirin for chemoprevention of hepato- cellular carcinoma: Time to use or wait further?
Goh, MJ; Sinn, DH
View PubMed
-
FRONT ONCOL 2022 10.3389/fonc.2022.888755
Safety and Efficacy of Liver-Directed Radiotherapy in Combination With Lenvatinib for Hepatocelluar Carcinoma With Macroscopic Tumor Thrombosis
Yu, JI; Kang, W; Yoo, GS; Goh, MJ; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW; Hong, JY; Lim, HY; Park, B; Park, HC
View PubMed
-
SCI REP-UK 2022 10.1038/s41598-022-11736-1
Prognostic significance of cachexia index in patients with advanced hepatocellular carcinoma treated with systemic chemotherapy
Goh, MJ; Kang, W; Jeong, WK; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
View PubMed
-
ESMO OPEN 2021 10.1016/j.esmoop.2021.100330
Nonalcoholic steatohepatitis in hepatocarcinoma: new insights about its prognostic role in patients treated with lenvatinib
Rimini, M; Kudo, M; Tada, T; Shigeo, S; Kang, W; Suda, G; Jefremow, A; Burgio, V; Iavarone, M; Tortora, R; Marra, F; Lonardi, S; Tamburini, E; Piscaglia, F; Masi, G; Cabibbo, G; Foschi, FG; Silletta, M; Kumada, T; Iwamoto, H; Aoki, T; Goh, MJ; Sakamoto, N; Siebler, J; Hiraoka, A; Niizeki, T; Ueshima, K; Sho, T; Atsukawa, M; Hirooka, M; Tsuji, K; Ishikawa, T; Takaguchi, K; Kariyama, K; Itobayashi, E; Tajiri, K; Shimada, N; Shibata, H; Ochi, H; Yasuda, S; Toyoda, H; Fukunishi, S; Ohama, H; Kawata, K; Tani, J; Nakamura, S; Nouso, K; Tsutsui, A; Nagano, T; Takaaki, T; Itokawa, N; Okubo, T; Arai, T; Imai, M; Joko, K; Koizumi, Y; Hiasa, Y; Cucchetti, A; Ratti, F; Aldrighetti, L; Cascinu, S; Casadei-Gardini, A
View PubMed
-
HEPATOLOGY 2020 10.1002/hep.31079
Letter to the Editor: Statins and Reduced Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B REPLY
Goh1, MJ; Kim, S; Woo, SY; Sinn, DH
View PubMed
